Evaluate therapeutic effects on the immune response and specific immunity pathways.
ImmuneProfiler is a suite of assays that can be customized to determine a compounds properties on the immune response. We offer a variety of in vivo models and in vitro assays for evaluating select pathways. Sponsors can select pathways of interest, choose between stimulation or inhibition assays, evaluate in cell based or whole animal systems.
Readouts include:
Category | Species | Response | Output |
Cellular Immunity | mouse | Th1 response | cytokine panel, FACS |
Cellular Immunity | mouse | Th2 response | cytokine panel, FACS |
Cellular Immunity | mouse | Th17 response | cytokine panel, FACS |
Cellular Immunity | mouse | CD8 T cell response | cytokine panel, FACS |
Non-specific Immunity | mouse | innate | cytokine panel, FACS |
Humoral Immunity | mouse | B cell response | FACS, cytokines |
Humoral Immunity | mouse | B cell activation | FACS |
Allergy/Hypersensitivity | mouse/rat | Th1 | cytokines, FACS |
Allergy/Hypersensitivity | mouse | Th2 | cytokines, FACS |
Pathway | System | Stimulant | Output |
Th17 activation | PBMC | antiCD3 | cytokine panel, FACS |
T cell inhibition | PBMC | antiCD3/CD28, ConA, PHA | cytokine panel, FACS |
T cell stimulation | PBMC | sponsor compound | cytokine panel, FACS |
Cytokine Release | PBMC | sponsor compound | cytokine panel, FACS |
Macrophage (Inhibition) | PBMC | LPS | cytokine panel, FACS |
Macrophage (stimulation) | PBMC | sponsor compound | cytokine panel, FACS |
Proliferation - (stimulate) | PBMC | sponsor compound | CFSE |
Proliferation - (inhibition) | PBMC | anti-CD3/CD28, ConA, PHA | CFSE |